<DOC>
	<DOCNO>NCT01053702</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , parallel-group , single-dose study efficacy REGN475 patient pain due thermal injury .</brief_summary>
	<brief_title>Study Safety Efficacy REGN475 ( SAR164877 ) Patients With Pain Resulting From Thermal Injury</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<criteria>1 . Males female , age 18 50 , hospitalize result thermal injury 2 . Moderate severe procedural pain intensity ( wound care ) initial assessment day 1 . Patients burn cause chemical exposure electricity 2 . Patients inhalation injury evidence pneumonia , cellulitis , infection 3 . Patients traumatic musculoskeletal injury ( eg , bone fracture dislocation ) traumatic head chest injuries 4 . Significant preinjury concomitant illness , limited , cardiac , renal , neurological , endocrinological , metabolic , psychiatric ( include significant anxiety depression ) , lymphatic disease , drug dependence ( alcohol drug abuse ) , would adversely affect patient 's management , recovery , affect mortality patient 's compliance protocol assessment . 5 . Women pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>